Vol. 277, Issue 3, C531-C536, September 1999
Phosphoinositide 3-kinase is required for
aldosterone-regulated sodium reabsorption
Bonnie L.
Blazer-Yost1,
Teodor
G.
P
unescu2,
Sandy I.
Helman2,
Kimberly D.
Lee1, and
Chris J.
Vlahos3
1 Biology Department, Indiana
University, Purdue University at Indianapolis, Indianapolis 46202;
3 Lilly Research Laboratories, Eli
Lilly and Company, Indianapolis, Indiana 46285; and
2 Department of Molecular and
Integrative Physiology, University of Illinois at Urbana-Champaign,
Urbana, Illinois 61801
 |
ABSTRACT |
Aldosterone, a steroid hormone, regulates renal
Na+ reabsorption and, therefore,
plays an important role in the maintenance of salt and water balance.
In a model renal epithelial cell line (A6) we have found that
phosphoinositide 3-kinase (PI 3-kinase) activity is required for
aldosterone-stimulated Na+
reabsorption. Inhibition of PI 3-kinase by the specific inhibitor LY-294002 markedly reduces both basal and aldosterone-stimulated Na+ transport. Further, one of the
products of PI 3-kinase, phosphatidylinositol 3,4,5-trisphosphate, is
increased in response to aldosterone in intact A6 monolayers. This
increase occurs just before the manifestation of the functional effect
of the hormone and is also inhibited by LY-294002. With the use of
blocker-induced noise analysis, it has been demonstrated that
inhibition of phosphoinositide formation causes an inhibition of
Na+ entry in both control and
aldosterone-pretreated cultures by reducing the number of open
functional epithelial Na+ channels
(ENaCs) in the apical membrane of the A6 cells. These novel
observations indicate that phosphoinositides are required for ENaC
expression and suggest a mechanism for aldosterone regulation of
channel function.
epithelial sodium channels; noise analysis; electrophysiology; kidney; cortical collecting ducts; A6 cell line
 |
INTRODUCTION |
SEVERAL HORMONES MODULATE the activity of the renal
epithelial Na+ channel (ENaC).
This regulation is critical to maintain normal salt and fluid
homeostasis, and slight alterations in these hormone-stimulated pathways may contribute to such common diseases as essential
hypertension. Despite the importance of these processes, very little is
known about the intracellular signaling pathways involved in hormonal regulation of epithelial Na+ reabsorption.
Aldosterone, a steroid hormone, mediates relatively long-term
natriferic responses. Hormone binding to the mineralocorticoid receptor
in responsive tissues is well documented. Likewise, it is known that
the final outcome of this interaction is stimulation of
Na+ transport via the
amiloride-sensitive ENaCs (1-4, 8). However, the pathway(s)
linking the aldosterone-receptor binding to activation of transport
through functional channels within the apical membrane of the cells is unknown.
Phosphoinositide 3-kinases (PI 3-kinases) are enzymes that
phosphorylate position 3 of the head group of the membrane lipid phosphatidylinositol (20). PI 3-kinases are a family of enzymes that
can be distinguished by molecular characteristics, substrate specificity, and inhibitor sensitivities (13, 20, 22-24). Classic inhibitors of these enzymes are wortmannin, a fungal metabolite, which
is an irreversible inhibitor effective in the nanomolar concentration
range, and LY-294002, a structurally unrelated compound with a very
high specificity for PI 3-kinase, which is a reversible inhibitor
effective in the micromolar concentration range (23).
These enzymes have been implicated in a variety of diverse biochemical
processes including membrane transport phenomena. Notable in this
regard is the importance of the activation of PI 3-kinase for the
insertion of the glucose transporters (GLUT-4) into the plasma membrane
of adipocytes and skeletal muscle in response to insulin (6, 24).
However, other peptide hormone-mediated transport events including
insulin-stimulated Na+ transport
via ENaC (14) and K+ uptake into
fibroblasts via the
Na+-K+-2Cl
cotransporter (19) also require PI 3-kinase activation. In addition,
these enzymes also appear to have a role in platelet-derived growth
factor activation of the
Na+/H+
exchanger (11), epidermal growth factor (EGF)-stimulated intestinal Na+ absorption (9), and
EGF-mediated inhibition of
Ca2+-dependent
Cl
secretion (21).
We have previously shown that the increase in aldosterone-stimulated
Na+ transport is paralleled by an
increase in the number of functional channels in the apical membrane
(8). In this regard, the steroid hormone action is similar to the
natriferic action of insulin, although the time course of the two
hormones is very different. Insulin causes an increase in the number of
functional channels within minutes, whereas aldosterone's action
requires a longer time, consistent with the requirement for new protein
synthesis (4). We have also previously demonstrated that insulin's
action is dependent on the presence of PI 3-kinase (14). Given the importance of PI 3-kinase for peptide-mediated transport, we have investigated the role of this enzyme in steroid-mediated
Na+ absorption.
 |
MATERIALS AND METHODS |
Cell culture. For measurement of
macroscopic rates of transport as well as lipid profile analysis, the
A6 cells were grown at 27°C in DMEM (#91-5055EC;
GIBCO BRL, Grand Island, NY) supplemented with 25 U/ml penicillin, 25 µg/ml streptomycin, and 10% calf serum in a humidified incubator
gassed with 5% CO2. The cells
were subcultured onto 24-mm Transwell tissue-culture-treated inserts
(Costar, Cambridge, MA) for at least 14 days to achieve confluence and
used 14-21 days after seeding. For noise analysis, with the
exception of three control tissues, A6 epithelia were grown on
Transwell clear inserts at 28°C in a humidified incubator
containing 1% CO2. The growth
medium was either the modified DMEM (as above) or a mixture of Ham's
F-12 medium (N-6760; Sigma Chemical, St. Louis, MO) and L-15 Leibovitz
medium (L-4386; Sigma Chemical) supplemented with 10% defined fetal
bovine serum (FBS), 2.57 mM sodium bicarbonate, 3.84 mM
L-glutamine, 96 U/ml penicillin,
and 96 µg/ml streptomycin. Tissues were studied while continuously
perfused with growth medium without FBS and glutamine.
Electrical measurements/noise
analysis. Macroscopic rates of transcellular
Na+ transport were measured as
short-circuit currents
(Isc) as
previously described (2, 8). After mounting in the chambers, the cells were incubated in serum-free media for 1-4 h to assure that a stable baseline was achieved before the addition of inhibitors and/or hormone.
In the noise experiments, blocker-sensitive
Na+ currents
(INa) were
determined from the difference between the
Isc and the respective 100 µM amiloride-insensitive
Na+ currents that average near 0.1 µA/cm2 before and after
treatment of the tissues with LY-294002. A pulse method of
blocker-induced noise analysis was carried out as previously described
(8), using the weak ENaC blocker
6-chloro-3,5-diaminopyrazine-2-carboxamide (CDPC; 27,788-6;
Aldrich Chemical, Milwaukee, WI). Corner frequencies (fc) and
low-frequency plateaus
(So) of the
CDPC Lorentzians characterizing the blocker-induced current noise in
power density spectra were determined by nonlinear curve fitting.
Blocker on
(kob) and off (kbo) rate
coefficients were calculated from the slopes and intercepts of
rate-concentration plots using the time-filtered
fc at the respective 10 and 30 µM concentrations of CDPC. Single-channel currents (iNa)
were calculated in the usual way from the quotient [So(2
fc)2]/[4INa
kobB],
where So were
corrected for the shunting of current noise (~12%) through the
apical membrane capacitance. Functional open-channel densities
(No) were
calculated as
INa/iNa.
The tissues were studied in both their unstimulated and
aldosterone-prestimulated states (0.27 µM, overnight). All
experiments were carried out at ambient room temperature. Data are
expressed as means ± SE.
Lipid analysis. To determine the
phosphorylation of the inositol lipids, A6 cells were incubated for 16 h in serum-free media followed by a 2-h incubation in a nominally
phosphate-free media containing
H332PO4
before any experimental manipulations were performed. After hormone
and/or inhibitor treatments, the lipids were extracted, separated, and
analyzed by anion exchange chromatography as reported previously (14,
23).
 |
RESULTS |
When A6 epithelia are challenged with LY-294002, a specific and
reversible inhibitor of PI 3-kinase (23), inhibition of PI 3-kinase
results in a marked decrease in basal
Na+ transport and a complete
abolition of aldosterone-stimulated Na+ transport as measured by
amiloride-sensitive
Isc. To
illustrate the time course of the basal inhibition, the data are
plotted at 5-min intervals in the 30 min following the addition of
LY-294002 (Fig.
1A).
Such observations suggest that the products of the PI 3-kinase
reaction, phosphoinositides, may be crucial intermediates in the
natriferic pathway.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of inhibitors of phosphoinositide 3-kinase (PI 3-kinase) on
basal and aldosterone-stimulated
Na+ transport. Macroscopic rates
of ion transport were measured as short-circuit currents
(Isc). A6
tissues were preincubated with 50 µM LY-294002
(A) or 100 nM wortmannin
(B) for 30 min. Aldosterone (2.7 µM) was added to basolateral solution at time
zero. After 5 h of aldosterone incubation, 10 µM
amiloride was added to apical media to inhibit portion of current due
to Na+ transport by epithelial
Na+ channels (ENaCs). Results are
means ± SE. For clarity, error bars are shown in one direction
only.
|
|
Interestingly, wortmannin, a structurally unrelated inhibitor of PI
3-kinase (13), also inhibited basal current but did not affect the
aldosterone-stimulated portion of
Na+ transport (Fig.
1B). Thus the data suggest that the
baseline rate of Na+ transport
requires the constitutive activation of a wortmannin- and
LY-294002-sensitive PI 3-kinase, whereas aldosterone's action involves
an LY-294002-sensitive but wortmannin-insensitive form of the kinase.
Because intracellular signaling processes must occur before the final
functional effect manifested by the cell, the phosphatidylinositol lipid profile was examined just before the onset of
aldosterone-stimulated transport (20 min after hormone addition) and
just after an aldosterone-induced increase in transport was clearly
measurable (60 min). The lipid profiles of stimulated tissues were
compared with control (non-hormone-treated) tissues that had been grown
in parallel cultures (Fig. 2). Twenty minutes after the addition of aldosterone, there was an increase in the phosphoinositides phosphatidylinositol 3-phosphate
[PtdIns(3)P] and
phosphatidylinositol 3,4,5-trisphosphate
[PtdIns(3,4,5)P3]. Accurate
quantitation of PtdIns(3)P as well as phosphatidylinositol 3,4-bisphosphate
[PtdIns(3,4)P2]
was not possible in all experiments due to the proximity of these
compounds to unidentified peaks that have a similar elution time. For
this reason, the
PtdIns(3,4,5)P3 peak, which can be accurately quantitated, was used as the measure of
PI 3-kinase activity in a more extensive series of experiments (Fig. 3).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Inhibition of aldosterone-stimulated PI 3-kinase in A6 cells.
A: a single, representative experiment
showing increase in 3-phosphorylated phosphatidylinositols in response
to aldosterone (20 and 60 min of hormonal stimulation) and inhibition
of this increased activity by LY-294002 after 60 min of hormone
stimulation. B: an experiment
demonstrating effect of LY-294002 on aldosterone-stimulated tissues 20 min after addition of the hormone. For inhibitor studies,
32PO4-labeled
A6 cells were preincubated with 50 µM LY-294002 for 30 min before
addition of aldosterone. Each panel represents lipid components from
two 5-cm2 Transwell inserts of
confluent A6 cells. Standards of
[32P]phosphatidylinositol
3-phosphate (PI-3P), phosphatidylinositol 3,4-bisphosphate
(PI-3,4P2), and
phosphatidylinositol 3,4,5-trisphosphate
(PIP3) were synthesized
using purified bovine brain PI 3-kinase. For each experiment,
standards that were run at time of sample analysis are shown.
* Position of phosphatidylinositol 4,5-bisphosphate. CPM,
counts/min.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of aldosterone and LY-294002 on phosphoinositide production in
A6 cells. Ratio of phosphatidylinositol 3,4,5-trisphosphate
(PIP3) to phosphatidylinositol
4,5-bisphosphate (PIP2) was
calculated for each sample and compared with same ratio in control
(untreated) cells that were grown in parallel and assayed in tandem.
Time indicates length of time of treatment with aldosterone. In
inhibitor-treated samples, LY-294002 was added 30 min before addition
of aldosterone. Each bar represents an individual sample. When
LY-294002-treated samples are shown in same vertical space as
aldosterone alone, these represent samples within same experiment where
cells were grown, labeled, and analyzed in tandem.
|
|
To normalize for experimental variability due to sample recovery, the
PtdIns(3,4,5)P3
peak was compared with the
PtdIns(4,5)P2 peak in each sample. The amount of
PtdIns(4,5)P2 is
not likely to change under these experimental conditions. The
PtdIns(3,4,5)P3/PtdIns(4,5)P2 ratio from each sample was compared with the same ratio in a control sample that was grown, labeled, and processed in tandem (Fig. 3).
An increased level of
PtdIns(3,4,5)P3
is detectable before a measurable increase in aldosterone-stimulated
Na+ transport (20 min) in each
sample analyzed. After 60 min of hormone stimulation,
PtdIns(3,4,5)P3
remains elevated over control in all samples. With one exception,
LY-294002 inhibits the production of
PtdIns(3,4,5)P3
below control levels even in the presence of aldosterone. Thus
LY-294002 inhibited not only the aldosterone-mediated increase in the
production of the phosphoinositides (Fig. 2 and 3) but also the
Na+ transport response (Figs. 1
and 4).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Inhibition of Na+ transport by
LY-294002. A pulse method of blocker-induced noise analysis was used to
determine time-dependent changes of single-channel current
(B) and functional open-channel
density (No) of
apical membrane ENaCs (C) in
unstimulated and aldosterone-pretreated tissues in response to apical
10 µM LY-294002. Completely reversible inhibition of macroscopic
rates of Na+ transport measured as
amiloride-sensitive
Isc
(A) is due to relatively slow
time-dependent changes of
No. Values are
means ± SE; n = 5 for unstimulated
tissues; n = 7 for
aldosterone-pretreated tissues.
|
|
Finally, we determined the underlying time-dependent changes of
amiloride-sensitive Na+ transport
(INa) in
response to LY-294002 at the single-channel level. Noninvasive methods
of blocker-induced noise analysis were used to monitor the changes of
the single-channel currents
(iNa) and
open-channel densities
(No) in
confluent short-circuited monolayers of A6 epithelia. For the purpose
of these studies, the effects of the inhibitor on both unstimulated and
aldosterone-pretreated tissues were examined (Fig. 4). Zero time values
shown in Fig. 4 are typical of those reported for unstimulated and
aldosterone-pretreated tissues where aldosterone causes a twofold or
larger stimulation of transport by increase of
No with no
significant change of
iNa (8). From
zero time values of
INa that averaged
4.0 ± 0.1 µA/cm2 in
unstimulated tissues and 9.1 ± 0.9 µA/cm2 in aldosterone-pretreated
tissues, the amiloride-sensitive
Isc were
inhibited by LY-294002, on average, to 33% and 38% of the zero time
values, respectively, within 90 min (Fig.
4A), following, however, an initial
small transient increase in transport (<5 min, data not shown). The
inhibitory effect was relatively slow, with the mean
INa response to
10 µM LY-294002 exhibiting quasiexponential decays with time
constants of 22.4 and 24.4 min in control and aldosterone-pretreated
tissues, respectively.
The changes of single-channel current caused by the inhibitor in the
two groups of tissues are summarized in Fig.
4B. From zero time values that
averaged ~0.39 pA, LY-294002 caused similar small time-dependent
increases of iNa.
Consequently, the inhibitory effect of LY-294002 on
Na+ transport is due to a decrease
in the number of functionally open channels within the apical membrane
of the cells. Underlying the trend in
INa,
No fell on
average to 30% and 34% of the respective zero time values in control
and aldosterone-pretreated tissues, respectively, after 90 min of
exposure to LY-294002. Inhibition of the macroscopic rates of transport
and open-channel densities is fully reversible on removal of the
LY-294002 (Fig. 4).
 |
DISCUSSION |
Tight epithelia of the A6 cell line, derived from the kidney of
Xenopus laevis, are commonly used as a
model for the transport properties of the principal cells of the distal
nephron. A6 cells contain ENaCs and respond to hormones known to
regulate Na+ reabsorption in the
mammalian distal nephron (12). In these cells, aldosterone stimulates
an increase in transepithelial Na+
transport with a slow time course that is consistent with its action
through new protein synthesis (3). The nature of the induced proteins
as well as the identity of other intracellular regulators of the
hormone-stimulated transport process are unknown.
Taken together, the data presented here indicate that PI 3-kinases are
required for transcellular Na+
transport with specific involvement of apical membrane ENaCs. Analysis
of the lipid profile in A6 cells that have been treated with
aldosterone indicates that this steroid hormone mediates an increase in
the amount of phosphoinositides, specifically
PtdIns(3,4,5)P3. This increase over the level found in control cells can be detected before the increase in the functional effect of enhanced
Na+ transport, consistent with a
regulatory role for the phosphoinositides in aldosterone-mediated
natriferic activity. These results are similar to our previous studies
that showed that insulin-mediated Na+ reabsorption via ENaC also
involves the stimulation of an LY-294002-sensitive PI 3-kinase and that
the
PtdIns(3,4,5)P3
formed by this enzyme is increased before the functional action on the
channel (14). Insulin and aldosterone exhibit additive natriferic
responses, suggesting that they are mediated by at least partially
independent pathways (15). However, both hormone responses are a result of an increase in the number of active ENaCs in the apical membrane (4,
8). The similarities in PI 3-kinase inhibitor effects on the two
hormone responses suggest that the enzyme may be mediating an effect at
or near the channel.
PI 3-kinases play pivotal roles in a wide variety of metabolic
processes. Specificity in the regulation of these diverse pathways may
be explained, in part, by the growing number of PI 3-kinase variants
that have been described recently (7, 14, 20, 22). Multiple variants
can coexist in a single cell. In fact, four different isoforms of PI
3-kinase have been identified in adipocytes. Our results indicate that
both basal Na+ transport as well
as the aldosterone-stimulated portion of the natriferic activity are
sensitive to inhibition by LY-294002, whereas only the basal transport
is inhibited by wortmannin. Again, this is consistent with our previous
studies showing that the insulin-stimulated increase in
Na+ transport is a
wortmannin-insensitive, LY-294002-sensitive process, whereas basal
transport is sensitive to both inhibitors (14). These data suggest that
at least two variants of PI 3-kinase are involved in transcellular
Na+ transport.
LY-294002 inhibition of transport assessed macroscopically and at the
single-channel level is fully reversible after removal of LY-294002,
indicating the dynamic role of PI 3-kinase in regulation of transport.
Notably, inhibition of transport is essentially the same for both
control and aldosterone-pretreated tissues, indicating the importance
of PI 3-kinase for functional expression of ENaCs.
The time course of the inhibitory effect in both basal and
aldosterone-pretreated tissues is relatively slow. These results can be
compared with the data of Kurashima et al. (10) who found that
inhibitors of PI 3-kinase alter the constitutive endosomal recycling of
the
Na+/H+
exchanger NHE3. The time course of the inhibitory effect on the functional activity of the exchanger in intact cells was remarkably similar to the inhibition of Na+
transport in our study. It is also worth noting that ENaC has been
shown to be a relatively short-lived protein with an estimated half
time of ~1 h (18). The data obtained in the Kurashima
studies suggested that the functional effects were likely due to a
decrease in the cycling of intracellular
Na+/H+
exchangers to the plasma membrane (10). Although the very low number of
endogenous Na+ channels in our
native epithelial cells makes similar studies examining recycling very
difficult, we have examined the effect of LY-294002 on the number of
active channels expressed on the apical membrane of A6 cells. When the
inhibitory effect was assessed at a single-channel level, we found that
the effect on macroscopic transport is clearly due to a decrease in the
number of active channels in the apical membrane (Fig. 4). Although
this result, combined with the relatively slow time course, is
certainly consistent with a role for PI 3-kinase in dynamic recycling
of Na+ channels, it should be
noted that these biophysical measurements of active channels cannot
distinguish between insertion of new channels from an intracellular
pool and activation of quiescent channels that were preexisting in the membrane.
ENaC has been shown to be involved in rare forms of blood pressure
aberrations (5, 17) and has been implicated as a potential factor in
many forms of essential hypertension (16). Therefore, a complete
elucidation of the hormonal pathways that regulate the activity of the
channel is important to understand the etiology of pathological
processes that may arise from aberrant regulation of this signaling.
These studies provide evidence of a crucial role for phosphoinositide
formation in aldosterone-stimulated Na+ transport and represent novel
data regarding the intracellular pathway linking mineralocorticoid
receptor binding to the final natriferic effect in transporting
epithelial cells. Although PI 3-kinases have been linked to a variety
of peptide factor transport responses, this is the first demonstration
of a role for these enzymes in a steroid hormone response.
 |
ACKNOWLEDGEMENTS |
We thank T. Lahr and R. Yost for critically reviewing the manuscript.
 |
FOOTNOTES |
This work was supported by grants from the American Heart Association,
Indiana Affiliate (to B. Blazer-Yost), and the National Institutes of
Health (to S. I. Helman).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: B. L. Blazer-Yost, Biology Dept., SL 358, Indiana Univ., Purdue Univ. at
Indianapolis, 723 W. Michigan St., Indianapolis IN 46202 (E-mail:
bblazer{at}iupui.edu).
Received 28 September 1998; accepted in final form 28 May 1999.
 |
REFERENCES |
1.
Barbry, P.,
and
M. Lazdunski.
Structure and regulation of the amiloride-sensitive epithelial sodium channel.
In: Ion Channels, edited by T. Narahashi. New York: Plenum, 1996, vol. 4, p. 115-167.
2.
Blazer-Yost, B. L.,
Y. Fesseha,
and
M. Cox.
Aldosterone-mediated Na+ transport in renal epithelia: time course of induction of a potential regulatory component of the conductive Na+ channel.
Biochem. Int.
26:
887-897,
1992[Medline].
3.
Blazer-Yost, B. L.,
M. Geheb,
A. Preston,
J. Handler,
and
M. Cox.
Aldosterone-induced proteins in renal epithelia.
Biochim. Biophys. Acta
719:
158-161,
1982[Medline].
4.
Blazer-Yost, B. L.,
X. Liu,
and
S. I. Helman.
Hormonal regulation of ENaCs: insulin and aldosterone.
Am. J. Physiol.
274 (Cell Physiol. 43):
C1373-C1379,
1998[Abstract/Free Full Text].
5.
Chang, S. S.,
S. Grunder,
A. Hanukoglu,
A. Rosler,
P. M. Mathew,
I. Hanukoglu,
L. Schild,
Y. Lu,
R. A. Shimkets,
C. Nelson-Williams,
B. C. Rossier,
and
R. P. Lifton.
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
Nat. Genet.
12:
248-253,
1996[Medline].
6.
Cheatham, B.,
C. J. Vlahos,
L. Cheatham,
L. Wang,
J. Blenis,
and
C. R. Kahn.
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.
Mol. Cell. Biol.
14:
4902-4911,
1994[Abstract/Free Full Text].
7.
Dey, B. R.,
R. W. Furlanetto,
and
S. P. Nissley.
Cloning of human p55
, a regulatory subunit of phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor.
Gene
209:
175-183,
1998[Medline].
8.
Helman, S. I.,
X. Liu,
K. Baldwin,
B. Blazer-Yost,
and
W. J. Els.
Time-dependent stimulation by aldosterone of blocker-sensitive ENaCs in A6 epithelia.
Am. J. Physiol.
274 (Cell Physiol. 43):
C947-C957,
1998[Abstract/Free Full Text].
9.
Khurana, S.,
S. K. Nath,
S. A. Levine,
J. M. Bowser,
C.-M. Tse,
M. E. Cohen,
and
M. Donowitz.
Brush border phosphatidylinositol 3-kinase mediates epidermal growth factor stimulation of intestinal NaCl absorption and Na+/H+ exchange.
J. Biol. Chem.
271:
9919-9927,
1996[Abstract/Free Full Text].
10.
Kurashima, K.,
E. Z. Szabo,
G. Lukas,
J. Orlowski,
and
S. Grinstein.
Endosomal recycling of the Na+/H+ exchanger NHE3 isoform is regulated by the phosphatidylinositol 3-kinase pathway.
J. Biol. Chem.
273:
20828-20836,
1998[Abstract/Free Full Text].
11.
Ma, Y. H.,
H. P. Reusch,
E. Wilson,
J. A. Escobedo,
W. J. Fantl,
L. T. Williams,
and
H. E. Ives.
Activation of Na+/H+ exchange by platelet-derived growth factor involves phosphatidylinositol 3'-kinase and phospholipase C
.
J. Biol. Chem.
269:
30734-30739,
1994[Abstract/Free Full Text].
12.
Perkins, F. M.,
and
J. S. Handler.
Transport properties of toad kidney epithelia in culture.
Am. J. Physiol.
241 (Cell Physiol. 10):
C154-C159,
1981[Abstract/Free Full Text].
13.
Powis, G.,
R. Bonjouklian,
M. M. Berggren,
A. Gallegos,
R. Abraham,
C. Ashendel,
L. Zalkow,
W. F. Matter,
J. Dodge,
G. Grindey,
and
C. J. Vlahos.
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Cancer Res.
54:
2419-2423,
1994[Abstract/Free Full Text].
14.
Record, R. D.,
L. Froelich,
C. J. Vlahos,
and
B. L. Blazer-Yost.
Phosphatidylinositol 3-kinase activation is required for insulin-stimulated sodium transport in A6 cells.
Am. J. Physiol.
274 (Endocrinol. Metab. 37):
E611-E617,
1998[Abstract/Free Full Text].
15.
Record, R. D.,
M. Johnson,
S. Y. Lee,
and
B. L. Blazer-Yost.
Aldosterone and insulin stimulate amiloride-sensitive sodium transport in A6 cells by additive mechanisms.
Am. J. Physiol.
271 (Cell Physiol. 40):
C1079-C1084,
1996[Abstract/Free Full Text].
16.
Rossier, B. C.
Cum grano salis: the epithelial sodium channel and control of blood pressure.
J. Am. Soc. Nephrol.
9:
980-992,
1997.
17.
Skimkets, R. A.,
D. G. Warnock,
C. M. Bositis,
C. Nelson-Williams,
J. H. Hansson,
M. Schambelan,
J. R. Gill,
S. Ulick,
R. V. Milora,
J. W. Findling,
C. M. Canessa,
B. C. Rossier,
and
R. P. Lifton.
Liddle's syndrome: heritable human hypertension caused by mutations in the subunit of the epithelial sodium channel.
Cell
79:
407-414,
1994[Medline].
18.
Staub, O.,
I. Gautschi,
T. Ishikawa,
K. Breitschopf,
A. Ciechanover,
L. Schild,
and
D. Rotin.
Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination.
EMBO J.
16:
6325-6336,
1997[Medline].
19.
Sweeney, G.,
R. Somwar,
T. Ramlal,
P. Martin-Vasallo,
and
A. Klip.
Insulin stimulation of K+ uptake in 3T3-L1 fibroblasts involves phosphatidylinositol 3-kinase and protein kinase C-
.
Diabetologia
41:
1199-1204,
1998[Medline].
20.
Toker, A.,
and
L. C. Cantley.
Signalling through the lipid products of phosphoinositide-3-OH kinase.
Nature
387:
673-676,
1997[Medline].
21.
Uribe, J. M.,
S. J. Keely,
A. E. Traynor-Kaplan,
and
K. Barrett.
Phosphatidylinositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion.
J. Biol. Chem.
271:
26588-26595,
1996[Abstract/Free Full Text].
22.
Virbasius, J. V.,
A. Guilherme,
and
M. P. Czech.
Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain.
J. Biol. Chem.
271:
13304-13307,
1996[Abstract/Free Full Text].
23.
Vlahos, C. J.,
W. F. Matter,
K. Y. Hui,
and
R. F. Brown.
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
J. Biol. Chem.
269:
5241-5248,
1994[Abstract/Free Full Text].
24.
Yeh, J.-I.,
A. E. Gulve,
L. Rameh,
and
M. J. Birnbaum.
The effects of wortmannin on rat skeletal muscle.
J. Biol. Chem.
270:
2107-2111,
1995[Abstract/Free Full Text].
Am J Physiol Cell Physiol 277(3):C531-C536
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society